Akebia Therapeutics, Inc. (NASDAQ:AKBA) announced on 21 march Initial public offering of 5,882,353 shares of common stock was set at $17.00 per share. In addition, Akebia has granted the underwriters a 30-day over-allotment option to purchase up to an additional 879,647 shares of common stock at the initial public offering price. On last trading day Akebia Therapeutics Inc. (NASDAQ:AKBA) ended up -0.99%lower to close at $20.00 while trading in the range of $18.96 – $20.50.
GeoMet, Inc. (OTCMKTS:GMET) announced yesterday that it has established the close of business on March 26, 2014 as the record date (the “Record Date”) for its special meeting of stockholders to consider and vote on the Company’s sale of substantially all of its assets to ARP Mountaineer Production, LLC, a wholly-owned subsidiary of Atlas Resource Partners, L.P., a Delaware limited partnership (the “Asset Sale”), pursuant to the previously announced Asset Purchase Agreement dated February 13, 2014. GeoMet Inc. in last trading activity ended up at $0.0149 with day range of $0.01 – $0.01. Company weekly performance is -25.50% while its quarterly performance stands at -75.17%.GeoMet Inc. is -94.04% away from its 52 week high.
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of the small-loan consumer finance company, World Acceptance Corporation (NASDAQ:WRLD), breached their fiduciary duties to shareholders. World Acceptance Corp. belongs to Financial sector with market capitalization of 815.20 million and has 4.40% insider ownership. In last trading activity company’s stock closed at $72.76 while opening price was $74.61.
VirnetX Holding Corp.was the recipient of a large increase in short interest in the month of January. As of March 14th, there was short interest totalling 17,547,300 shares, an increase of 10.0% from the February 28th total of 15,955,445 shares, Analyst Ratings.Net reports. Based on an average daily volume of 1,895,175 shares, the short-interest ratio is presently 9.3 days. On Tuesday shares of VirnetX Holding Corporation (NYSEMKT:VHC) opened at $14.14 and closed at $13.82. This year Company’s Earnings per Share (EPS) growth is -0.54 and next year’s estimated EPS growth is 216.70%. Analysts mean target price for VirnetX Holding Corporation (NYSEMKT:VHC) is $42.33.